The mechanisms of EGCG anti-cancer activity are based on the properties of apoptosis induction, cell proliferation arrest, angiogenesis inhibition, and influence on inflammatory and oxidative pathways, which are mediated by the nuclear factor-kappa B (NF-κB), STAT3, and PI3K/AKT/mTOR axis (89). Here, NFKB1 is linked to cancer.